Brief: ABIONYX Pharma FY Operating Cash Flow EUR -2.9 Million

Abionyx Pharma SA

12/03/2026 17:00

Mar 12 (Reuters) - ABIONYX Pharma FY EBIT EUR -5.5 million.

FY net income EUR -5.5 million